Simplified Access Speeds EPR Adoption and Ensures Support for The Department of Health’s QIPP Flexible Working Standards
London, UK – June 12, 2012 - Imprivata®, Inc., the leader in secure access and collaboration for healthcare, today announced that The Royal Liverpool and Broadgreen University Hospitals NHS Trust (Royal Liverpool) has implemented Imprivata OneSign® across two sites covering 5000 users. As the Trust shifts from paper to electronic patient records (EPRs) in the interest of overall efficiency and improved care, Imprivata OneSign has substantially improved productivity, allowing clinicians to spend less time on authenticating to the system and more time with patients. Following the project’s completion, the Trust achieved its return on investment in just one year as a result of workflow efficiency improvements, strongly positioning Royal Liverpool to meet targets set out by the Department of Health’s Quality, Innovation, Production and Prevention (QIPP) programme.
After selecting a clinical portal solution that would allow a single view of a patient's information aggregated from 200 disparate clinical and administration systems, Royal Liverpool required a single sign-on (SSO) solution which would enable users fast and secure access to all systems without the need to log-on to each application separately – a process that can take minutes rather than seconds to complete each time a record is accessed. Successful adoption of the clinical portal was central to the Trust’s Information Management and Technology strategy, so in order to eliminate user frustration and productivity loss associated with multiple passwords and log-ins, a competitive analysis of SSO solutions was conducted, and Imprivata OneSign was chosen for its ease of use both from end-user and technology integration perspective when compared with competitive products.
Imprivata OneSign manages credentials behind the scenes, allowing an authorised user to log-in just once and be granted access to all applications required for that person’s role. This was a huge priority for end- users at the outset of the project who identified simplified authentication as a key strategic requirement to guarantee that EPR systems could be securely and effectively accessed. Following completion of the project, clinicians have spent up to 30-40 minutes less per day accessing data – Royal Liverpool estimates that up to 2 minutes are saved per patient from a data entry perspective, resulting from a reduction in the time taken to authenticate and access patient records, register details in case notes and file notes accurately.
Increasing the speed and security of access management has benefitted both clinicians and patients alike, particularly as the number of errors associated with the handling of patient data has reduced following the project’s completion, allowing for significant improvements in quality of service. Following the success of the project to date, Royal Liverpool plans to extend OneSign to support a virtual desktop deployment which will enable mobile clinical workers to securely access patient data on-the-go. Plans are also underway to combine legacy smart card technology with the OneSign solution, offering second factor authentication across the hospital sites.
James Norman, Director of Information Management and Technology at the Trust stated, “As a University teaching hospital and centre of excellence for research and innovation, Royal Liverpool and Broadgreen University Hospitals NHS Trust aims to lead the way in delivering the tools which allow clinicians to carry out their work to the best of their abilities while also realising significant efficiency savings in line with government directives. The implementation of EPRs and a clinical portal was key to this process for us, and Imprivata OneSign has been instrumental in our success. As a result of simplified and streamlined access, we have seen significant improvements in staff workflow and productivity which has not only translated to cost savings, but also to improved patient care across the board.”
“As the NHS shifts from paper to electronic records, Trusts are recognising that the rate of adoption and usage of these systems is critical to the success of their projects, as well as to achieving the overall goal of improved patient care,” said Ed Gaudet, Chief Marketing Officer at Imprivata. “Imprivata has worked closely with clinicians to ensure that OneSign promotes efficiency whilst keeping data secure and that has resulted in a critical role for OneSign in the EPR adoption and usage process. I am delighted to see that the University Royal Liverpool and Broadgreen University Hospitals NHS Trust is using OneSign to drive efficiency improvements through supporting its clinical portal and EPR programme.”
To learn more about Imprivata, please visit www.imprivata.com.
With more than 2 million users and 900 healthcare customers, Imprivata is the #1 provider of secure access and collaboration solutions for healthcare. By strengthening user authentication, streamlining application access and simplifying compliance reporting across multiple computing environments, customers realize improved workflows, increased security and compliance with government regulations.
Imprivata has received numerous product awards and top review ratings from leading industry publications and analysts, including the Frost & Sullivan 2012 NA Customer Value Enhancement Award for healthcare IT, a Strong Positive rating in Gartner’s 2011 Marketscope for ESSO, the #1 ranking in the KLAS SSO Performance report and the #1 rating in 2010 Best in KLAS and Category Leaders report. Headquartered in Lexington, Mass., Imprivata partners with over 200 resellers, and serves the access security and collaboration needs of customers around the world. For more information, please visit www.imprivata.com or follow us on Twitter at @Imprivata.